Atum, Phylex accelerate universal SARS coronavirus vaccine

By The Science Advisory Board staff writers

June 15, 2020 -- Atum and Phylex BioSciences will collaborate to advance research toward creating a universal vaccine effective against pathogenic coronaviruses, including the novel coronavirus SARS-CoV-2.

Through the partnership, Atum will utilize its Leap-in-Transposase platform to develop the cell line required for Phylex's universal severe acute respiratory syndrome (SARS) coronavirus vaccine candidate.

The Phylex antigen candidate contains epitopes similar to the receptor-binding domain of the SARS coronavirus spike protein. Copies of the antigen are displayed on a virus-like particle that self-assembles after being secreted by the cell line in development by Atum.

The collaboration will enable Phylex to develop the vaccine candidate while simultaneously conducting immunogenicity studies, noted co-founder and Chief Executive Officer Pascal Brandys in a press release. Brandys added that the company's objective is to develop a universal vaccine candidate with an associated manufacturing and clinical development plan by fall 2020.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here